Latest stories on NYXH
NYXH Maintains Rating by Cantor Fitzgerald -- Price Target Lowered to $3.00
GuruFocus42 · neutralanalyst
Nyxoah price target lowered to $3 from $6 at Cantor Fitzgerald
The Fly34 · bearishanalyst
Nyxoah Sets Date for Q3 2026 Results as Genio Sleep Apnea Therapy Scales Globally
TipRanks56 · neutralearnings
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
GlobeNewswire50 · neutralgeneral
Nyxoah to Release Third Quarter 2026 Financial Results on November 5, 2026
Business Insider50 · neutralgeneral
Nyxoah cuts FY26 revenue view to EUR 33M-EUR 35M from EUR 36M-EUR 40M
The Fly34 · bearishearnings
Nyxoah reports preliminary Q3 revenue EUR 9.2M, consensus EUR 9.93M
The Fly38 · neutralearnings
Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026
GlobeNewswire52 · neutralearnings
Nyxoah’s Genio Device Shows Strong 12-Month Results in U.S. Sleep Apnea Trial
TipRanks74 · bullishproduct/pr
Nyxoah presents complete ACCCESS U.S. study data, submits PMA supplement to FDA
The Fly64 · neutralproduct/pr
Nyxoah: Label Expansion Set To Unlock A Monopoly In A Billion Dollar Market.
Seeking Alpha73 · bullishproduct/pr
At a glance: stocks gapping down premarket
Seeking Alpha38 · neutralgeneral
Nyxoah names new CEO
Seeking Alpha55 · neutralgeneral
Nyxoah names Liam Kelly as CEO, succeeding Olivier Taelman
The Fly50 · neutralgeneral
Nyxoah Appoints Liam Kelly as Chief Executive Officer
GlobeNewswire55 · neutralgeneral
Nyxoah Appoints Liam Kelly as Chief Executive Officer
Business Insider55 · neutralgeneral
Nyxoah names Loïc Moreau as interim CFO
Seeking Alpha50 · neutralgeneral
Nyxoah announces CFO transition
The Fly50 · neutralgeneral
Nyxoah shares fall after CFO departure announcement
Investing.com Markets38 · neutralgeneral
Nyxoah Announces Chief Financial Officer Transition
GlobeNewswire50 · neutralgeneral
Cantor Fitzgerald reiterates Nyxoah stock Overweight rating at $6
Investing.com Analyst Ratings61 · neutralanalyst
Nyxoah (NYXH) Begins BREATHE Study. Can Real-World Evidence Drive Genio Adoption?
Yahoo Top58 · neutralproduct/pr
Nyxoah Launches Major U.S. Post-Approval Study for Genio Sleep Apnea Device
TipRanks63 · neutralproduct/pr
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
GlobeNewswire63 · neutralproduct/pr
Nyxoah Announces First Patient Implanted in BREATHE, the U.S. Post-Approval Study of the Genio® System
Business Insider63 · neutralproduct/pr